CardiaTec Bio Revenue

Biotechnology Research • Cambridge, England, United Kingdom • 11-20 Employees

CardiaTec Bio revenue & valuation

Annual revenue	$1,454,435
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,700,000
Total funding	$8,200,000

Key Contacts at CardiaTec Bio

Thelma Zablocki

Co-Founder & Coo

Raphael Peralta

Co-Founder, Ceo @ Cardiatec

Franck Duclos

Director Cardiovascular Biosciences

Company overview

Headquarters	Cambridge, England, United Kingdom
Website	cardiatec.ai
NAICS	541714
Founded	2021
Employees	11-20
Socials

CardiaTec Bio Email Formats

CardiaTec Bio uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@cardiatec.ai), used 42.9% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@cardiatec.ai	42.9%
{first name}{last name}	johndoe@cardiatec.ai	42.9%
{last name}{last name}	doedoe@cardiatec.ai	14.3%

About CardiaTec Bio

CardiaTec is a TechBio company employing computational methods to decode the biology behind cardiovascular disease. The company leverages human multiomics data to better navigate complex disease biology to identify novel and differentiated therapeutics. CardiaTec is building the first and largest proprietary human heart tissue multiomics dataset. The company has a large and growing network of over 65 hospitals across the US and the UK, screening patients on a 24/7 basis to support the bespoke collection of human cardiac tissues. The company spun out of the Han Lab at the University of Cambridge and has brought together industry experts from leading organisations including Bristol Myers Squibb, Cleveland Clinic and Recursion Pharmaceuticals.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

CardiaTec Bio has 5 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore CardiaTec Bio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-08-06	2	$1,700,000
2024-10-10	3	$6,500,000

Funding Insights

$8,200,000

Total funding amount

$6,500,000

Most recent funding amount

Number of funding rounds

CardiaTec Bio Tech Stack

Discover the technologies and tools that power CardiaTec Bio's digital infrastructure, from frameworks to analytics platforms.

Slick

JavaScript libraries

MonsterInsights

Analytics

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

LiteSpeed

Web servers

HTTP/3

Miscellaneous

Motion.page

WordPress plugins

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Frequently asked questions

CardiaTec Bio is located in Cambridge, England, GB.

CardiaTec Bio generates an estimated annual revenue of $1,454,435. This revenue figure reflects the company's market position and business performance in its industry.

CardiaTec Bio has an estimated valuation of $4,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CardiaTec Bio was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

CardiaTec Bio has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

CardiaTec Bio has raised a total of $8,200,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at CardiaTec Bio

Thelma Zablocki

Co-Founder & Coo

Raphael Peralta

Co-Founder, Ceo @ Cardiatec

Franck Duclos

Director Cardiovascular Biosciences

4.8

40,000 users